The Latest

THE LATEST Health

THE LATEST THINKING

Terminal prostate cancer patients could get 'two more years of life' with experimental drug

Photo by: Daily Mail

Men at end-stage cancer trialled pembrolizumab. A small number of 'super responders' saw their disease 'disappear', scientists at The Institute of Cancer Research, London, said.

See article

THE LATEST THINKING

The opinions of THE LATEST’s guest contributors are their own.

Searching for TLT's ...

Video Site Tour

The Latest
The Latest

Subscribe to THE LATEST Newsletter.

The Latest
The Latest

Share this story through...

Separate multiple emails with commas. That's not a valid e-mail.